Dr Daniele Bolognini

  • Research Associate (Institute of Molecular Cell & Systems Biology)

telephone: 01413302254
email: Daniele.Bolognini@glasgow.ac.uk

Publications

List by: Type | Date

Jump to: 2020 | 2019 | 2018 | 2017 | 2016 | 2015
Number of items: 10.

2020

Bolognini, D., Dedeo, D. and Milligan, G. (2020) Metabolic and inflammatory functions of short chain fatty acid receptors. Current Opinion in Endocrine and Metabolic Research, (Accepted for Publication)

2019

Bolognini, D. et al. (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nature Chemical Biology, 15(5), pp. 489-498. (doi: 10.1038/s41589-019-0270-1) (PMID:30992568)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi: 10.1053/j.gastro.2018.12.002) (PMID:30550821)

Mancini, S., Mahmud, Z. A., Jenkins, L. , Bolognini, D., Newman, R., Barnes, M., Edye, M. E., McMahon, S. B., Tobin, A. B. and Milligan, G. (2019) On-target and off-target effects of novel orthosteric and allosteric activators of GPR84. Scientific Reports, 9, 1861. (doi: 10.1038/s41598-019-38539-1) (PMID:30755705) (PMCID:PMC6372602)

2018

Hansen, A. H., Sergeev, E. , Bolognini, D., Sprenger, R. R., Ekberg, J. H., Ejsing, C. S., McKenzie, C. J., Rexen Ulven, E., Milligan, G. and Ulven, T. (2018) Discovery of a potent thiazolidine free fatty acid receptor 2 agonist with favorable pharmacokinetic properties. Journal of Medicinal Chemistry, 61(21), pp. 9534-9550. (doi: 10.1021/acs.jmedchem.8b00855) (PMID:30247908)

2017

Sergeev, E. , Hansen, A. H., Bolognini, D., Kawakami, K., Kishi, T., Aoki, J., Ulven, T., Inoue, A., Hudson, B. D. and Milligan, G. (2017) A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias. Scientific Reports, 7, 13741. (doi: 10.1038/s41598-017-14096-3) (PMID:29061999) (PMCID:PMC5653858)

Milligan, G. , Bolognini, D. and Sergeev, E. (2017) Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41). In: Milligan, G. and Kimura, I. (eds.) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology (236). Springer International Publishing, pp. 17-32. ISBN 9783319506920 (doi:10.1007/164_2016_49)

2016

Bolognini, D. et al. (2016) A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias. Journal of Biological Chemistry, 291, pp. 18915-18931. (doi: 10.1074/jbc.M116.736157) (PMID:27385588) (PMCID:PMC5009265)

Bolognini, D., Tobin, A. B., Milligan, G. and Moss, C. E. (2016) The pharmacology and function of receptors for short-chain fatty acids. Molecular Pharmacology, 89(3), pp. 388-398. (doi: 10.1124/mol.115.102301) (PMID:26719580)

2015

Smoum, R. et al. (2015) CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences of the United States of America, 112(28), pp. 8774-8779. (doi: 10.1073/pnas.1503395112) (PMID:26124120)

This list was generated on Thu Jul 9 02:05:41 2020 BST.
Number of items: 10.

Articles

Bolognini, D., Dedeo, D. and Milligan, G. (2020) Metabolic and inflammatory functions of short chain fatty acid receptors. Current Opinion in Endocrine and Metabolic Research, (Accepted for Publication)

Bolognini, D. et al. (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nature Chemical Biology, 15(5), pp. 489-498. (doi: 10.1038/s41589-019-0270-1) (PMID:30992568)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi: 10.1053/j.gastro.2018.12.002) (PMID:30550821)

Mancini, S., Mahmud, Z. A., Jenkins, L. , Bolognini, D., Newman, R., Barnes, M., Edye, M. E., McMahon, S. B., Tobin, A. B. and Milligan, G. (2019) On-target and off-target effects of novel orthosteric and allosteric activators of GPR84. Scientific Reports, 9, 1861. (doi: 10.1038/s41598-019-38539-1) (PMID:30755705) (PMCID:PMC6372602)

Hansen, A. H., Sergeev, E. , Bolognini, D., Sprenger, R. R., Ekberg, J. H., Ejsing, C. S., McKenzie, C. J., Rexen Ulven, E., Milligan, G. and Ulven, T. (2018) Discovery of a potent thiazolidine free fatty acid receptor 2 agonist with favorable pharmacokinetic properties. Journal of Medicinal Chemistry, 61(21), pp. 9534-9550. (doi: 10.1021/acs.jmedchem.8b00855) (PMID:30247908)

Sergeev, E. , Hansen, A. H., Bolognini, D., Kawakami, K., Kishi, T., Aoki, J., Ulven, T., Inoue, A., Hudson, B. D. and Milligan, G. (2017) A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias. Scientific Reports, 7, 13741. (doi: 10.1038/s41598-017-14096-3) (PMID:29061999) (PMCID:PMC5653858)

Bolognini, D. et al. (2016) A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias. Journal of Biological Chemistry, 291, pp. 18915-18931. (doi: 10.1074/jbc.M116.736157) (PMID:27385588) (PMCID:PMC5009265)

Bolognini, D., Tobin, A. B., Milligan, G. and Moss, C. E. (2016) The pharmacology and function of receptors for short-chain fatty acids. Molecular Pharmacology, 89(3), pp. 388-398. (doi: 10.1124/mol.115.102301) (PMID:26719580)

Smoum, R. et al. (2015) CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences of the United States of America, 112(28), pp. 8774-8779. (doi: 10.1073/pnas.1503395112) (PMID:26124120)

Book Sections

Milligan, G. , Bolognini, D. and Sergeev, E. (2017) Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41). In: Milligan, G. and Kimura, I. (eds.) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology (236). Springer International Publishing, pp. 17-32. ISBN 9783319506920 (doi:10.1007/164_2016_49)

This list was generated on Thu Jul 9 02:05:41 2020 BST.